Streetbeat News

SIGA

SIGA Technologies, Inc.

https://www.siga.com

Industry

Drug Manufacturers - Specialty & Generic

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.

Open

5.47

Mkt cap

399M

Volume

459K

High

5.59

P/E Ratio

6.80

52-wk high

12.83

Low

5.36

Div yield

0.11

52-wk low

5.16

SIGA Technologies reported Q2 losses of $(0.04) per share, a 233.33% decrease YoY. The company's sales also decreased by 64.73% to $5.88 million compared to $16.67 million in the same period last year.

Portfolio Pulse from bharat@benzinga.com

August 08, 2023 | 8:30 pm

The article lists the stocks that gained and lost the most during Friday's mid-day trading session. Among the gainers were Unique Fabricating, Reata Pharmaceuticals, and Bluejay Diagnostics, while the losers included Tonix Pharmaceuticals, Sleep Number Corporation, and Femasys Inc. Avantor shares fell by 9.9% due to worse-than-expected Q2 financial results.

Portfolio Pulse from Lisa Levin

July 28, 2023 | 5:07 pm

Several US stocks traded higher on Friday, with the Nasdaq Composite gaining around 200 points. Notable gainers include Reata Pharmaceuticals, which rose 53.3% after Biogen agreed to acquire the company, Roku, which gained 20.8% after reporting better-than-expected Q2 results and strong Q3 guidance, and The Boston Beer Company, which surged 18.1% after reporting better-than-expected quarterly results. Other companies that saw significant gains include Business First Bancshares, Huron Consulting Group, TAL Education Group, Costamare, Coursera, Beazer Homes USA, Celestica, SIGA Technologies, Silicon Motion Technology Corporation, UP Fintech Holding Limited, SkyWest, GDS Holdings Limited, Dada Nexus Limited, Cardlytics, AVITA Medical, T. Rowe Price Group, Opendoor Technologies, Meritage Homes Corporation, Skechers U.S.A., Chart Industries, DISH Network Corporation, Upstart Holdings, DexCom, and Intel Corporation.

Portfolio Pulse from Lisa Levin

July 28, 2023 | 2:47 pm

The Indian government has reported 27 confirmed cases of monkeypox disease in the country, with 12 cases in Kerala and 15 in Delhi. The World Health Organization (WHO) has declared an outbreak of monkeypox disease as a Public Health Emergency. The treatment for the disease remains largely supportive.

Portfolio Pulse from Happy Mohamed

July 28, 2023 | 2:35 pm

Several healthcare stocks experienced significant movement in Friday's pre-market session. Gainers included Reata Pharmaceuticals, Bluejay Diagnostics, SIGA Technologies, Homology Medicines, Creative Medical Tech, and Asensus Surgical. Losers included Tonix Pharmaceuticals, Bellerophon Therapeutics, Femasys, Telesis Bio, Mallinckrodt, and Titan Pharma.

Portfolio Pulse from Benzinga Insights

July 28, 2023 | 1:06 pm

Intel's Q2 EPS of $0.13 beat the estimate of $(0.03), and sales of $12.95B also surpassed the estimate of $12.14B. SIGA announced U.S. government procurement orders worth approximately $138 million for Oral and IV TPOXX. DexCom's Q2 adjusted EPS of $0.34 beat the estimate of $0.23, and sales of $871.30M also beat the estimate of $841.62M.

Portfolio Pulse from ryanfaloona@benzinga.com

July 28, 2023 | 12:33 pm

Several stocks are experiencing significant pre-market movements. Coursera shares are up by 15.3% following better-than-expected Q2 sales results and an upgrade from Cantor Fitzgerald. Other gainers include Unique Fabricating, Greenbrook TMS, SIGA Technologies, Homology Medicines, Inpixon, AEye, Navidea Biopharmaceuticals, Intel Corporation, and Asensus Surgical. Losers include Tonix Pharmaceuticals, Sleep Number Corporation, Bellerophon Therapeutics, Mallinckrodt, Fresh Vine Wine, Enphase Energy, Femasys, Sigma Additive Solutions, Sweetgreen, and Yoshiharu Global.

Portfolio Pulse from Lisa Levin

July 28, 2023 | 11:57 am

Several healthcare stocks experienced significant movement in Thursday's after-market session. Gainers included SIGA Technologies, Homology Medicines, INVO Bioscience, AIM ImmunoTech, electroCore, and vTv Therapeutics. Losers included Tonix Pharmaceuticals, Femasys, Mettler-Toledo Intl, Inozyme Pharma, MyMD Pharmaceuticals, and Reshape Lifesciences.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 9:32 pm

SIGA Technologies Inc. has secured a $138 million contract from the US government for oral and IV TPOXX treatment. This news has led to an increase in the company's share prices.

Portfolio Pulse from Bill Haddad

July 27, 2023 | 9:25 pm

SIGA Technologies, Inc. has announced that it has received procurement orders from the U.S. government worth approximately $138 million for oral and IV TPOXX.

Portfolio Pulse from Bill Haddad

July 27, 2023 | 8:45 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.